Immunologic, genetic, and ecological interplay of factors involved in allergic diseases
RMG Falcon, SEC Caoili - Frontiers in Allergy, 2023 - frontiersin.org
An allergic or type I hypersensitivity reaction involves a misdirected immune overreaction to
innocuous environmental and dietary antigens called allergens. The genetic predisposition …
innocuous environmental and dietary antigens called allergens. The genetic predisposition …
Specific Immunotherapy in Hymenoptera Venom Allergy and Concomitant Malignancy: A Retrospective Follow-up Focusing on Effectiveness and Safety.
J Aeberhard, G Haeberli, UR Müller… - … allergology & clinical …, 2017 - europepmc.org
Background Malignancies are often considered a contraindication for allergen-specific
immunotherapy. Consequently, patients with severe Hymenoptera venom allergy and …
immunotherapy. Consequently, patients with severe Hymenoptera venom allergy and …
[图书][B] Apiterapia: medicamentos das abelhas e possíveis tratamentos
Os produtos apícolas têm sido utilizados há séculos por vários povos para o tratamento de
diversas enfermidades. Nos dias atuais, seu consumo vem aumentando, seja na forma de …
diversas enfermidades. Nos dias atuais, seu consumo vem aumentando, seja na forma de …
Exclusive bee venom allergy: risk factors and outcome of immunotherapy
Y Rosman, F Nashef, A Cohen-Engler… - … Archives of Allergy and …, 2019 - karger.com
Introduction: Venom immunotherapy (VIT) is considered to be the gold-standard treatment
for patients with Hymenoptera venom allergy. Data regarding VIT in bee venom (BV) allergic …
for patients with Hymenoptera venom allergy. Data regarding VIT in bee venom (BV) allergic …
Risk factors in bee and Vespula venom allergy: state of the art
J Stoevesandt, A Trautmann - Allergo Journal International, 2021 - Springer
Background Correct recognition of risk factors enables individualized management and
treatment of venom allergic patients. Methods Systematic research and review of current …
treatment of venom allergic patients. Methods Systematic research and review of current …
Component-Resolved Evaluation of the Risk and Success of Immunotherapy in Bee Venom Allergic Patients
M Rosiek-Biegus, R Pawłowicz, A Kopeć… - Journal of Clinical …, 2022 - mdpi.com
Venom immunotherapy (VIT) is the only efficient therapy for the Hymenoptera insect venom
allergy. Immunotherapy with bee venom is encumbered with a higher risk of systemic side …
allergy. Immunotherapy with bee venom is encumbered with a higher risk of systemic side …
Nutzen und Limitationen der Stichprovokation bei Hymenopterengiftallergie
K Aßmus, M Meissner, R Kaufmann… - Allergologie, 2021 - search.proquest.com
Die Prävalenz systemischer Reaktionen auf Hymenopterenstiche liegt bei bis zu 7, 5%. Zur
Behandlung einer bestehenden Insektengiftallergie hat sich die venomspezifische …
Behandlung einer bestehenden Insektengiftallergie hat sich die venomspezifische …
[HTML][HTML] Advancing allergy practice in India for respiratory physician
SS Samajdar, S Moitra - The Journal of Association of Chest …, 2024 - journals.lww.com
The landscape of allergy practice in India is undergoing transformative changes, shifting
from traditional symptom management to embracing advanced diagnostic and therapeutic …
from traditional symptom management to embracing advanced diagnostic and therapeutic …
Immunothérapie allergénique aux venins d'hyménoptères: doses et espacement des rappels–quelle conduite à tenir à long terme?
C Schwartz - Revue Française d'Allergologie, 2019 - Elsevier
Résumé L'immunothérapie allergénique aux venins d'hyménoptčres obéit ā des
recommandations bien définies mais le plus souvent établies sur des avis d'experts. Les …
recommandations bien définies mais le plus souvent établies sur des avis d'experts. Les …